Phase 4 Stroke Trial, Recruiting (NCT05260125)

Phase 4 Stroke Trial, Recruiting NCT05260125 Sponsor: Abant Izzet Baysal University Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05260125 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been experiencing shoulder pain on your affected (weaker) side after a stroke or similar condition for at least 3 months
You have moderate to significant shoulder pain (scoring more than 3 out of 10) when someone gently moves your affected shoulder for you

Who may not be able to join:

You have significant difficulties with memory or thinking, based on a standard mental awareness test score below 24
You have diabetes that is not well controlled, or a condition that affects your blood's ability to clot properly
You have received Botulinum toxin (such as Botox) injections in the past six months
You have had any type of injection into your shoulder area in the last six months
You have a known allergy or sensitivity to the substances used in the injections being tested in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Serdar kılınç, Abant Izzet Baysal University

Phone: 9050559113181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05260125

Sponsor: Abant Izzet Baysal University

Phase: Phase 4

Status: Recruiting

Condition: Stroke

Trial contact: 9050559113181

More information: https://clinicaltrials.gov/study/NCT05260125

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been experiencing shoulder pain on your affected (weaker) side after a stroke or similar condition for at least 3 months
You have moderate to significant shoulder pain (scoring more than 3 out of 10) when someone gently moves your affected shoulder for you

Who may not be able to join:

You have significant difficulties with memory or thinking, based on a standard mental awareness test score below 24
You have diabetes that is not well controlled, or a condition that affects your blood's ability to clot properly
You have received Botulinum toxin (such as Botox) injections in the past six months
You have had any type of injection into your shoulder area in the last six months
You have a known allergy or sensitivity to the substances used in the injections being tested in this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Abant Izzet Baysal University

Registry

ClinicalTrials.gov

Start date

15 March 2022

Est. completion

30 March 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Shoulder Range of Motion; Shoulder Range of Motion; Shoulder Range of Motion; Shoulder Range of Motion; Visual Analogue Scale; Visual Analogue Scale; Visual Analogue Scale; Visual Analogue Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov